Sponsor or institution

Clinical trials and research at Jacobio Pharmaceuticals Co., Ltd.

• 7Clinical trials
• 2Countries

Newest trials

All recruiting trials (7)

• JAB-8263 in active rheumatoid arthritis

  A Phase 2a open-label study tests JAB-8263 in adults with active rheumatoid arthritis to see if it is safe and can have preliminary signs of benefit.

  Recruiting Phase 2 Jacobio Pharmaceuticals Co., Ltd. · Beijing, Beijing Municipality · NCT07684157

• Pan-KRAS inhibitor JAB-23E73 with chemotherapy for metastatic pancreatic cancer with KRAS changes

  This study tests whether adding the pan-KRAS inhibitor JAB-23E73 to standard chemotherapy can help people with metastatic pancreatic cancer that has KRAS alterations.

  Recruiting at 6 sites Phase 1/2 Jacobio Pharmaceuticals Co., Ltd. · Beijing, Beijing Municipality and 12 other locations · NCT07640295

• JAB-23E73 treatment for adults with advanced solid tumors that have KRAS changes

  This trial will try JAB-23E73, an oral pan-KRAS drug, to see if it is safe and helps adults with advanced solid tumors that carry KRAS mutations.

  Recruiting at 4 sites Phase 1/2 Jacobio Pharmaceuticals Co., Ltd. · Rochester, Minnesota and 3 other locations · NCT06973564

• Testing JAB-23E73 in patients with advanced solid tumors and KRAS mutations

  This study is testing a new drug called JAB-23E73 to see if it can help people with advanced solid tumors that have KRAS mutations.

  Recruiting at 17 sites Phase 1/2 Jacobio Pharmaceuticals Co., Ltd. · Hefei, Anhui and 31 other locations · NCT06959615

• Treatment with JAB-30355 for patients with advanced solid tumors and a specific genetic mutation

  This study is testing a new treatment called JAB-30355 to see if it can help adults with advanced solid tumors that have a specific genetic mutation called TP53 Y220C.

  Recruiting at 13 sites Phase 1/2 Jacobio Pharmaceuticals Co., Ltd. · Denver, Colorado and 14 other locations · NCT06386146

• Evaluating JAB-2485 for Advanced Solid Tumors

  This study is testing a new drug called JAB-2485 to see if it is safe and can help adults with advanced solid tumors, like certain types of breast cancer and lung cancer, who have already tried other treatments.

  Recruiting at 8 sites Phase 1/2 Jacobio Pharmaceuticals Co., Ltd. · Detroit, Michigan and 7 other locations · NCT05490472

• First-in-human use of JAB-8263 in adults with advanced solid and blood cancers

  This trial will try JAB-8263, a BET inhibitor pill, in adults with advanced solid tumors or blood cancers that have progressed after standard treatments.

  Recruiting Phase 1/2 Jacobio Pharmaceuticals Co., Ltd. · Tianjin, Tianjin Municipality · NCT04686682

Quick answers

How many clinical trials run by Jacobio Pharmaceuticals Co., Ltd. are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (6 trials), United States (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 6, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →